🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 10 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/05/2025 45,89 47,65 45,43 47,58 +4,00% 4,84% 688.500
28/05/2025 46,48 46,85 45,67 45,75 -1,46% 2,54% 665.000
27/05/2025 46,42 46,51 45,28 46,43 +1,69% 2,65% 850.600
23/05/2025 45,69 45,99 45,14 45,66 -0,54% 1,86% 486.200
22/05/2025 45,63 46,03 45,18 45,91 +0,20% 1,86% 901.600
21/05/2025 46,02 46,80 45,05 45,82 -1,69% 3,80% 832.200
20/05/2025 45,60 46,63 44,72 46,61 +2,28% 4,19% 535.200
19/05/2025 44,45 45,58 44,04 45,57 +2,43% 3,46% 551.800
16/05/2025 44,35 45,20 44,11 44,49 +0,18% 2,46% 647.000
15/05/2025 44,12 44,76 43,47 44,41 +1,46% 2,94% 625.800
14/05/2025 44,44 45,26 43,20 43,77 -1,13% 4,63% 840.100
13/05/2025 45,23 45,23 43,27 44,27 -2,21% 4,34% 910.100
12/05/2025 43,77 45,83 43,75 45,27 +5,35% 4,75% 1.000.800
09/05/2025 44,15 45,43 42,85 42,97 -2,16% 5,84% 671.200
08/05/2025 42,60 44,37 41,60 43,92 +1,93% 6,50% 1.100.700
07/05/2025 41,77 43,20 41,29 43,09 +2,57% 4,58% 1.360.400
06/05/2025 43,86 44,23 41,74 42,01 -5,13% 5,67% 807.800
05/05/2025 45,39 45,53 44,20 44,28 -2,70% 2,94% 876.700
02/05/2025 45,05 46,12 44,82 45,51 +1,16% 2,89% 644.100
01/05/2025 45,23 45,63 43,49 44,99 -1,81% 4,73% 739.500
30/04/2025 45,25 46,02 44,22 45,82 +0,44% 3,97% 860.800
29/04/2025 44,16 46,00 43,69 45,62 +2,77% 5,23% 1.254.800
28/04/2025 44,49 45,50 44,08 44,39 -0,22% 3,19% 592.400
25/04/2025 44,36 44,84 43,62 44,49 -0,80% 2,75% 634.300
24/04/2025 45,96 46,06 44,27 44,85 -2,84% 3,89% 859.900
23/04/2025 47,13 47,35 45,73 46,16 +0,68% 3,43% 1.416.200
22/04/2025 46,00 46,41 45,42 45,85 +0,11% 2,15% 774.800
21/04/2025 46,05 46,97 45,07 45,80 -1,04% 4,13% 1.189.700
17/04/2025 45,83 46,87 45,80 46,28 +1,05% 2,33% 517.400
16/04/2025 46,75 47,14 45,00 45,80 -2,45% 4,58% 1.329.900